-
Je něco špatně v tomto záznamu ?
Relationships between right ventricular function, body composition, and prognosis in advanced heart failure
V. Melenovsky, M. Kotrc, BA. Borlaug, T. Marek, J. Kovar, I. Malek, J. Kautzner,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, práce podpořená grantem
Grantová podpora
NT14050
MZ0
CEP - Centrální evidence projektů
Digitální knihovna NLK
Plný text - Článek
Zdroj
NLK
Free Medical Journals
od 1983 do Před 1 rokem
Open Access Digital Library
od 1998-01-01
- MeSH
- adiponektin krev MeSH
- distribuce tělesného tuku MeSH
- dysfunkce pravé srdeční komory patofyziologie ultrasonografie MeSH
- echokardiografie MeSH
- index tělesné hmotnosti MeSH
- kachexie patofyziologie MeSH
- lidé středního věku MeSH
- lidé MeSH
- následné studie MeSH
- natriuretický peptid typu B krev MeSH
- plicní hypertenze patofyziologie MeSH
- prognóza MeSH
- složení těla fyziologie MeSH
- srdeční frekvence fyziologie MeSH
- stupeň závažnosti nemoci MeSH
- systolické srdeční selhání mortalita patofyziologie MeSH
- věkové faktory MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
OBJECTIVES: This study sought to examine the relationships between right ventricular (RV) function, body composition, and prognosis in patients with advanced heart failure (HF). BACKGROUND: Previous studies investigating HF-related cachexia have not examined the impact of RV function on body composition. We hypothesized that RV dysfunction is linked to weight loss, abnormal body composition, and worsened prognosis in advanced HF. METHODS: Subjects with advanced HF (n = 408) underwent prospective assessment of body composition (skinfold thickness, dual-energy X-ray absorptiometry), comprehensive echocardiography, and blood testing. Subjects were followed up for adverse events (defined as death, transplantation, or circulatory assist device). RESULTS: Subjects with RV dysfunction (51%) had lower body mass index, lower fat mass index, and were more likely to display cachexia (19%). The extent of RV dysfunction correlated with greater antecedent weight loss and a lower fat/lean body mass ratio. Over a median follow-up of 541 days, there were 150 events (37%). Risk of event was greater in subjects with RV dysfunction (hazard ratio: 3.09 [95% confidence interval (CI): 2.18 to 4.45]) and cachexia (hazard ratio: 2.90 [95% CI: 2.00 to 4.12]) in univariate and multivariate analyses. Increased body mass index was associated with a lower event rate (HR per kg/m(2): 0.92 [95% CI: 0.88 to 0.96]), and this protection was mediated by a higher fat mass (0.91 [95% CI: 0.87 to 0.96]) but not a fat-free mass index (0.97 [95% CI: 0.92 to 1.03]). CONCLUSIONS: RV dysfunction and cardiac cachexia often coexist, have additive adverse impact, and might be mechanistically interrelated. Wasting of fat but not of lean mass was predictive of adverse outcome, suggesting that fat loss is either a surrogate of enhanced catabolism or adipose tissue is cardioprotective in the context of HF.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc14050866
- 003
- CZ-PrNML
- 005
- 20190920090738.0
- 007
- ta
- 008
- 140401s2013 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.jacc.2013.06.046 $2 doi
- 035 __
- $a (PubMed)23916933
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Melenovský, Vojtěch $7 xx0160847
- 245 10
- $a Relationships between right ventricular function, body composition, and prognosis in advanced heart failure / $c V. Melenovsky, M. Kotrc, BA. Borlaug, T. Marek, J. Kovar, I. Malek, J. Kautzner,
- 520 9_
- $a OBJECTIVES: This study sought to examine the relationships between right ventricular (RV) function, body composition, and prognosis in patients with advanced heart failure (HF). BACKGROUND: Previous studies investigating HF-related cachexia have not examined the impact of RV function on body composition. We hypothesized that RV dysfunction is linked to weight loss, abnormal body composition, and worsened prognosis in advanced HF. METHODS: Subjects with advanced HF (n = 408) underwent prospective assessment of body composition (skinfold thickness, dual-energy X-ray absorptiometry), comprehensive echocardiography, and blood testing. Subjects were followed up for adverse events (defined as death, transplantation, or circulatory assist device). RESULTS: Subjects with RV dysfunction (51%) had lower body mass index, lower fat mass index, and were more likely to display cachexia (19%). The extent of RV dysfunction correlated with greater antecedent weight loss and a lower fat/lean body mass ratio. Over a median follow-up of 541 days, there were 150 events (37%). Risk of event was greater in subjects with RV dysfunction (hazard ratio: 3.09 [95% confidence interval (CI): 2.18 to 4.45]) and cachexia (hazard ratio: 2.90 [95% CI: 2.00 to 4.12]) in univariate and multivariate analyses. Increased body mass index was associated with a lower event rate (HR per kg/m(2): 0.92 [95% CI: 0.88 to 0.96]), and this protection was mediated by a higher fat mass (0.91 [95% CI: 0.87 to 0.96]) but not a fat-free mass index (0.97 [95% CI: 0.92 to 1.03]). CONCLUSIONS: RV dysfunction and cardiac cachexia often coexist, have additive adverse impact, and might be mechanistically interrelated. Wasting of fat but not of lean mass was predictive of adverse outcome, suggesting that fat loss is either a surrogate of enhanced catabolism or adipose tissue is cardioprotective in the context of HF.
- 650 _2
- $a adiponektin $x krev $7 D052242
- 650 _2
- $a věkové faktory $7 D000367
- 650 _2
- $a složení těla $x fyziologie $7 D001823
- 650 _2
- $a distribuce tělesného tuku $7 D050218
- 650 _2
- $a index tělesné hmotnosti $7 D015992
- 650 _2
- $a kachexie $x patofyziologie $7 D002100
- 650 _2
- $a echokardiografie $7 D004452
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a následné studie $7 D005500
- 650 _2
- $a systolické srdeční selhání $x mortalita $x patofyziologie $7 D054143
- 650 _2
- $a srdeční frekvence $x fyziologie $7 D006339
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a plicní hypertenze $x patofyziologie $7 D006976
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a natriuretický peptid typu B $x krev $7 D020097
- 650 _2
- $a prognóza $7 D011379
- 650 _2
- $a stupeň závažnosti nemoci $7 D012720
- 650 _2
- $a dysfunkce pravé srdeční komory $x patofyziologie $x ultrasonografie $7 D018497
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Kotrč, Martin $u - $7 xx0230033
- 700 1_
- $a Borlaug, Barry A $u -
- 700 1_
- $a Marek, Tomáš $u - $7 xx0059973
- 700 1_
- $a Kovář, Jan, $u - $d 1952- $7 jn20040114001
- 700 1_
- $a Málek, Ivan, $u - $d 1942- $7 nlk20030129885
- 700 1_
- $a Kautzner, Josef, $u - $d 1957- $7 xx0037112
- 773 0_
- $w MED00002964 $t Journal of the American College of Cardiology $x 1558-3597 $g Roč. 62, č. 18 (2013), s. 1660-1670
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/23916933 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20140401 $b ABA008
- 991 __
- $a 20190920091130 $b ABA008
- 999 __
- $a ok $b bmc $g 1018002 $s 849446
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2013 $b 62 $c 18 $d 1660-1670 $i 1558-3597 $m Journal of the American College of Cardiology $n J. Am. Coll. Cardiol. $x MED00002964
- GRA __
- $a NT14050 $p MZ0
- LZP __
- $a Pubmed-20140401